Concurrent placement of SpaceOAR gel and gold fiducials during HoLEP: a case report

Meera B Ganesh; Briana S Kaplunov; Matthew S Lee; Mark A Assmus; Ashley E Ross; Joy Coleman; Amy E Krambeck

doi:10.1177/17562872211072637

Concurrent placement of SpaceOAR gel and gold fiducials during HoLEP: a case report

Ther Adv Urol. 2022 Jan 19:14:17562872211072637. doi: 10.1177/17562872211072637. eCollection 2022 Jan-Dec.

Authors

Meera B Ganesh¹, Briana S Kaplunov², Matthew S Lee³, Mark A Assmus³, Ashley E Ross³, Joy Coleman⁴, Amy E Krambeck³

Affiliations

¹ Feinberg School of Medicine, Northwestern University, 420 East Superior Street, Chicago, IL 60611, USA.
² Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
³ Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
⁴ Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Abstract

Herein, we describe a case of a patient diagnosed with prostate cancer (PCa) who presented with lower urinary tract symptoms (LUTS) and elevated Prostate Specific Antigen (PSA). He underwent Holmium Laser Enucleation of the Prostate (HoLEP) for his severe LUTS with concurrent placement of SpaceOAR gel and gold fiducials in preparation for radiation therapy (RT). After a successful operation, the patient underwent same-day discharge and catheter removal. He regained continence at 2 weeks and started RT at 9 weeks post-HoLEP. We present that concurrent placement of fiducials and SpaceOAR during HoLEP appears to be feasible, well tolerated and effective for PCa patients who elect RT.

Keywords: HoLEP and prostate cancer; SpaceOAR and HoLEP; gold fiducials and HoLEP.

Publication types

Case Reports